EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of perioperative dexmedetomidine on acute kidney injury after partial nephrectomy: a single-centre, randomised, double-blind, placebo-controlled trial

Hao Kong, Qiao-Li Yin, Mo Li, Zhen-Zhen Xu, Ning Zhang, Xiao-Nan Zhao, Zhong-Yuan Zhang

British Journal of Anaesthesia · 2025-11 · 135 (5) · 1212-1222

DOI: 10.1016/j.bja.2025.08.010 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2025-11. Verfasst von Hao Kong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Peking University First Hospital, Beijing, China. Electronic address: konghao2438@126.com. Hauptthemen laut MEDLINE: Dexmedetomidine, Acute Kidney Injury, Nephrectomy, Postoperative Complications. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Peking University First Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute kidney injury (AKI) is a frequent complication after partial nephrectomy. Dexmedetomidine appears to protect against kidney injury in both in vitro and in vivo. We tested the primary hypothesis that perioperative administration of dexmedetomidine would reduce the incidence of postoperative AKI after partial nephrectomy. METHODS: This randomised, double-blind, placebo-controlled trial was conducted in a tertiary care hospital in Beijing, China with 290 participants randomly assigned to receive dexmedetomidine or saline at a loading dose of 0.6 μg kg-1 followed by continuous infusion at 0.4 μg kg-1 h-1 intraoperatively. Dexmedetomidine (200 μg) was also used as an adjuvant for patient-controlled i.v. analgesia with sufentanil after surgery. The primary outcome was the incidence of AKI, defined according to the creatinine criteria of the KDIGO (Kidney Disease: Improving Global Outcomes) criteria for AKI. RESULTS: Two surgeries were cancelled after randomisation, leaving 288 participants (mean age [range]: 55 [20-79] yr; 32% female) for the modified intention-to-treat analysis. AKI occurred in 32/144 (22%) participants randomly assigned to dexmedetomidine, compared with 33/144 (23%) participants randomly assigned to saline (risk ratio 0.97; 95% confidence interval 0.63-1.49; P=0.888). Secondary outcomes, including postoperative serum cystatin C and serum creatinine levels and estimated glomerular filtration rate in postoperative 6 months, were not different between groups. The incidence of safety outcomes was similar in each group. CONCLUSIONS: Perioperative dexmedetomidine administration did not reduce postoperative AKI after partial nephrectomy. CLINICAL TRIAL REGISTRATION: ChiCTR2200059536.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineAcute Kidney InjuryNephrectomyPostoperative ComplicationsPerioperative CareHumansDouble-Blind MethodFemaleMaleMiddle AgedAgedAdultYoung AdultCreatinine

Stichwörter der Autor:innen

acute kidney injurycystatin Cdexmedetomidineestimated glomerular filtration ratepartial nephrectomy

Substanzen

DexmedetomidineCreatinine

Autor:innen und Institutionen

  • Department of Anaesthesiology, Peking University First Hospital, Beijing, China. Electronic address: konghao2438@126.com.
  • Department of Anaesthesiology, Peking University First Hospital Ningxia Women's and Children's Hospital, Yinchuan, China.
  • Department of Anaesthesiology, Peking University First Hospital, Beijing, China.
  • Department of Anaesthesiology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
  • Department of Anaesthesiology, Baoding No. 1 Central Hospital, Baoding, China.
  • Department of Urology, Peking University First Hospital, Beijing, China. Electronic address: 15810531228@yeah.net.

Förderung

  • Peking University First Hospital

Zitieren

APA

Kong, H., Yin, Q. L., Li, M., Xu, Z. Z., Zhang, N., Zhao, X. N., & Zhang, Z. Y. (2025). Effect of perioperative dexmedetomidine on acute kidney injury after partial nephrectomy: a single-centre, randomised, double-blind, placebo-controlled trial. British Journal of Anaesthesia, 135(5), 1212-1222. https://doi.org/10.1016/j.bja.2025.08.010

Vancouver

Kong H, Yin QL, Li M, Xu ZZ, Zhang N, Zhao XN, et al. Effect of perioperative dexmedetomidine on acute kidney injury after partial nephrectomy: a single-centre, randomised, double-blind, placebo-controlled trial. British Journal of Anaesthesia. 2025;135(5):1212-1222. doi:10.1016/j.bja.2025.08.010

BibTeX
@article{Kong2025,
  author = {Kong, Hao and Yin, Qiao-Li and Li, Mo and Xu, Zhen-Zhen and Zhang, Ning and Zhao, Xiao-Nan and Zhang, Zhong-Yuan},
  title = {Effect of perioperative dexmedetomidine on acute kidney injury after partial nephrectomy: a single-centre, randomised, double-blind, placebo-controlled trial},
  journal = {British Journal of Anaesthesia},
  year = {2025},
  volume = {135},
  number = {5},
  pages = {1212--1222},
  doi = {10.1016/j.bja.2025.08.010}
}
Kostenlos starten →